The application relies on the clinical profile established in the phase 3 PURPOSE 1 and PURPOSE 2 trials, which demonstrated superior efficacy in reducing incident HIV-1 infections.

Planned Parenthood is a health-center route for contraception, not a single national store with one checkout screen. As of May 2026, patients may pay $0 with ...

Yeztugo, a twice-yearly shot, could be the catalyst for stopping a recent spike in new HIV diagnoses. It's now available in Arizona. How to get it.

GLP-1 shots and pills both help regulate appetite and blood sugar. Learn the differences in effectiveness, cost, and who ...

PITTSBURGH, May 1, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that six abstracts on its investigational low-dose estrogen combined hormonal ...

Render Networks has announced $20m AUD in private equity growth funding alongside the acquisition of GIS software firm mPower Innovations, and extended its system of execution to electric ...

Osteoarthritis affects around 600 million people globally. It causes pain, stiffness and reduced joint function – most commonly in the knees, hands and hips. There’s currently no cure for ...

CLEVELAND, Ohio — A longer-acting medication may be more effective at helping pregnant women with opioid use disorder avoid illegal drugs, suggests new research from the University of Cincinnati.

SUPER-1 is a 52-week (26-week main phase plus 26-week extension phase), phase 3, treat-to-target trial investigating the efficacy and safety of once-weekly GZR4 versus once-daily insulin glargine U100 ...

In God Bless the Pill: The Surprising History of Contraception and Sexuality in American Religion (UNC Press, Apr.), Samira Mehta, a religion scholar at the University of Colorado, Boulder, upends the ...

March 26 (Reuters) - The U.S. Food and Drug ‌Administration has approved Novo Nordisk's (NOVOb.CO), opens new tab insulin injection, Awiqli, to control blood sugar levels in adults living with type ⁠2 ...